This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It uses a three-star scale (3=better than expected, 2=as expected, 1=worse than expected) to rate institutions across five common cardiovascular procedures: coronary artery bypass grafting (CABG); aorticvalve replacement (AVR); AVR and CABG; mitral valve replacement/repair (MVRR); and MVRR and CABG.
Publication date: Available online 1 February 2025 Source: The American Journal of Cardiology Author(s): Pernille Steen Bkke, Troels Hjsgaard Jrgensen, Gintautas Bieliauskas, Lars Sondergaard, Ole De Backer
In this study, the authors assessed the feasibility and diagnostic accuracy of a 5G cellular network and robotic arm-based remote echocardiographic system in an outpatient clinic based 20 kilometres away from Zhongshan Hospital. A total of 51 patients were enrolled from the outpatient cardiology clinic.
Introduction Severe aortic stenosis is a major cause of morbidity and mortality. The existing treatment pathway for transcatheter aorticvalve implantation (TAVI) traditionally relies on tertiary Heart Valve Centre workup. Methods The centre performing local workup implemented a novel TAVI referral pathway.
Background In congenital aortic stenosis (CAS), commissurotomy is an option in patients not suitable to receive a valve prosthesis. However, there is often a need for future additional interventions on the aorticvalve. The fate of the aorticvalve is, however, essentially unknown.
Aims The majority of patients with severe aortic stenosis (AS) planned for transcatheter aorticvalve implantation (TAVI) are elective outpatients. During the COVID-19 pandemic, the time between the heart team’s decision and TAVI increased due to limited healthcare resources.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content